申请人:Chackalamannil Samuel
公开号:US20070197628A1
公开(公告)日:2007-08-23
A compound having the general structure of Formula (I):
or a pharmaceutically acceptable salt, solvate, or ester thereof, is useful in treating diseases, disorders, or conditions such as obesity, metabolic disorders, addiction, diseases of the central nervous system, cardiovascular disorders, respiratory disorders, and gastrointestinal disorders.
具有公式(I)结构的化合物,或其药学上可接受的盐,溶剂合物或酯类,可用于治疗肥胖症,代谢性疾病,成瘾,中枢神经系统疾病,心血管疾病,呼吸系统疾病和胃肠道疾病等疾病,障碍或症状。